Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Patterson, Jan E.
2006.
Multidrug-Resistant Gram-Negative Pathogens Multiple Approaches and Measures for Prevention.
Infection Control & Hospital Epidemiology,
Vol. 27,
Issue. 9,
p.
889.
Lodise, Thomas P.
Miller, Chris
Patel, Nimish
Graves, Jeffrey
and
McNutt, Louise-Anne
2007.
Identification of Patients WithPseudomonas aeruginosaRespiratory Tract Infections at Greatest Risk of Infection With Carbapenem-Resistant Isolates.
Infection Control & Hospital Epidemiology,
Vol. 28,
Issue. 8,
p.
959.
Gasink, Leanne B.
Fishman, Neil O.
Nachamkin, Irving
Bilker, Warren B.
and
Lautenbach, Ebbing
2007.
Risk Factors for and Impact of Infection or Colonization With Aztreonam-Resistant Pseudomonas aeruginosa.
Infection Control & Hospital Epidemiology,
Vol. 28,
Issue. 10,
p.
1175.
Valenti, August J.
2007.
Antimicrobial Resistance: Problem Pathogens and Clinical Countermeasures.
p.
397.
Gasink, Leanne B.
Zaoutis, Theoklis E.
Bilker, Warren B.
and
Lautenbach, Ebbing
2007.
The categorization of prior antibiotic use: Impact on the identification of risk factors for drug resistance in case control studies.
American Journal of Infection Control,
Vol. 35,
Issue. 10,
p.
638.
Enoch, D.A.
Birkett, C.I.
and
Ludlam, H.A.
2007.
Non-fermentative Gram-negative bacteria.
International Journal of Antimicrobial Agents,
Vol. 29,
Issue. ,
p.
S33.
Onguru, Pinar
Erbay, Ayse
Bodur, Hurrem
Baran, Gulseren
Akinci, Esragul
Balaban, Neriman
and
Cevik, Mustafa Aydin
2008.
Imipenem-Resistant Pseudomonas aeruginosa : Risk Factors for Nosocomial Infections.
Journal of Korean Medical Science,
Vol. 23,
Issue. 6,
p.
982.
Merchant, Sanjay
Gast, Chris
Nathwani, Dilip
Lee, Michael
Quintana, Alvaro
Ketter, Nzeera
Friedland, Ian
and
Ingham, Michael
2008.
Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
Clinical Therapeutics,
Vol. 30,
Issue. 4,
p.
717.
Patel, Nimish
McNutt, Louise-Anne
and
Lodise, Thomas P.
2008.
Relationship between Various Definitions of Prior Antibiotic Exposure and Piperacillin-Tazobactam Resistance among Patients with Respiratory Tract Infections Caused by
Pseudomonas aeruginosa
.
Antimicrobial Agents and Chemotherapy,
Vol. 52,
Issue. 8,
p.
2933.
Fox, Barry C.
Shenk, Gail
Peterson, Dan
Spiegel, Carol A.
and
Maki, Dennis G.
2008.
Choosing more effective antimicrobial combinations for empiric antimicrobial therapy of serious gram-negative rod infections using a dual cross-table antibiogram.
American Journal of Infection Control,
Vol. 36,
Issue. 3,
p.
S57.
Hawkey, P. M.
2008.
The growing burden of antimicrobial resistance.
Journal of Antimicrobial Chemotherapy,
Vol. 62,
Issue. Supplement 1,
p.
i1.
Maragakis, Lisa L
Perencevich, Eli N
and
Cosgrove, Sara E
2008.
Clinical and economic burden of antimicrobial resistance.
Expert Review of Anti-infective Therapy,
Vol. 6,
Issue. 5,
p.
751.
López-Dupla, Miguel
Martínez, José-Antonio
Vidal, Francesc
Almela, Manuel
Soriano, Alex
Marco, Francesco
López, Josefina
Olona, Montserrat
and
Mensa, Josep
2009.
Previous ciprofloxacin exposure is associated with resistance to β-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolates.
American Journal of Infection Control,
Vol. 37,
Issue. 9,
p.
753.
Lautenbach, Ebbing
Synnestvedt, Marie
Weiner, Mark G.
Bilker, Warren B.
Vo, Lien
Schein, Jeff
and
Kim, Myoung
2009.
Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii.
Infection Control & Hospital Epidemiology,
Vol. 30,
Issue. 12,
p.
1186.
Martínez, José A.
Delgado, Esther
Martí, Sara
Marco, Francesc
Vila, Jordi
Mensa, Josep
Torres, Antoni
Codina, Carles
Trilla, Antoni
Soriano, Alex
Alquezar, Aitor
Castro, Pedro
and
Nicolás, José M.
2009.
Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients.
Intensive Care Medicine,
Vol. 35,
Issue. 3,
p.
439.
Goldstein, Ellie J. C.
Citron, Diane M.
Peraino, Victoria
Elgourt, Tanya
Meibohm, Anne R.
and
Lu, Shuang
2009.
Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of
Pseudomonas aeruginosa
.
Antimicrobial Agents and Chemotherapy,
Vol. 53,
Issue. 12,
p.
5122.
Eagye, Kathryn J.
Kuti, Joseph L.
and
Nicolau, David P.
2009.
Risk Factors and Outcomes Associated with Isolation of Meropenem High-Level-Resistant Pseudomonas aeruginosa.
Infection Control & Hospital Epidemiology,
Vol. 30,
Issue. 8,
p.
746.
Shigemi, Akari
Matsumoto, Kazuaki
Yaji, Keiko
Shimodozono, Yoshihiro
Takeda, Yasuo
Miyanohara, Hiroaki
Kawamura, Hideki
Orita, Michiyo
Tokuda, Koichi
Nishi, Junichiro
and
Yamada, Katsushi
2009.
Correlation between meropenem and doripenem use density and the incidence of carbapenem-resistant Pseudomonas aeruginosa.
International Journal of Antimicrobial Agents,
Vol. 34,
Issue. 6,
p.
589.
Shorr, Andrew F.
2009.
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit*.
Critical Care Medicine,
Vol. 37,
Issue. 4,
p.
1463.
Bou, R.
Lorente, L.
Aguilar, A.
Perpiñán, J.
Ramos, P.
Peris, M.
and
Gonzalez, D.
2009.
Hospital economic impact of an outbreak of Pseudomonas aeruginosa infections.
Journal of Hospital Infection,
Vol. 71,
Issue. 2,
p.
138.